Despite observing a substantial reduction in albuminuria in group 3 (73%, 95% CI 53% to 92%) compared to group 2 (55%, 95% CI 43% to 67%), the difference was 18% (95% Cl: −0.1% to 31%) and did not reach statistical significance ( p -value 0.07).
← all excerpts
Real-Life Experience on the Effect of SGLT2 Inhibitors vs. Finerenone vs. Combination on Albuminuria in Chronic Kidney Disease.
1
—
—